biopharmaceutical

Samsung to Invest USD 22 Billion on AI, 5G and Biopharmaceuticals

Samsung to Invest USD 22 Billion on AI, 5G and Biopharmaceuticals

Samsung plans to spend USD 22 Billion in the next three years on developing artificial intelligence, 5G, automotive electronic parts and biopharmaceuticals. This comes as part of the earlier announced USD 160 Billion investment on research, developm..

National Institute of Health partners with 11 Biopharma companies for Cancer Research

National Institute of Health partners with 11 Biopharma companies for Cancer Research

The National Institutes of Health and 11 biopharmaceutical companies today launched the Partnership for Accelerating Cancer Therapies (PACT). This is a five-year-public-private research collaboration totaling $215 million as part of the Cancer Moons..

Pfizer Considers the Sales of its Consumer Healthcare Business

Pfizer Considers the Sales of its Consumer Healthcare Business

On Tuesday, Pfizer Inc. (NYSE: PFE), the pharmaceutical giant, said that it is considering the sale or spin-off of its consumer healthcare business, whose brands include lip balm Chapstick and painkiller Advil.The company’s consumer healthcare..

Sage Therapeutics Shares Down, Trial Did Not Meet the Primary Endpoint

Sage Therapeutics Shares Down, Trial Did Not Meet the Primary Endpoint

Sage Therapeutics (NASDAQ: SAGE) shares are down about 15% after the a clinical-stage biopharmaceutical company announced the results from the Phase 3 STATUS Trial of did not meet the primary endpoint. The trial of brexanolone (SAGE-547) in the trea..

Insmed Incorporated Shares Jumped More than 100% After Positive Clinical Trial Data

Insmed Incorporated Shares Jumped More than 100% After Positive Clinical Trial Data

Insmed Incorporated (NASDAQ: INSM) stock jumped about 113% on Tuesday, after the biopharmaceutical company announced top-line data from its Phase 3 CONVERT study.The company announced that the global CONVERT study met its primary endpoint of culture..